For patients with head and neck mucosal sqaumous cell carcinoma, can stratified audiology risk profiles reduce rates of sensorineural hearing loss and increase patient quality of life?

Phoebe Shorter0 个研究点目标入组 100 人开始时间: 2015年11月30日最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•Histopathologically confirmed head and neck squamous cell carcinoma; all mucosal primary subsites accepted
•Tumour classified as stage II – IV, according to the TNM classification
•The patient must be a candidate for combined modality therapy, in either the definitive or postoperative setting
•The patient must be booked to received external beam radiotherapy at the Princess Alexandra Hospital
•Has provided written, informed consent for participation in the study

•Distant Metastases
•Palliative Radiotherapy
•Extension of disease into the auditory system
•Previous external beam radiotherapy to the head and neck region
•Incomplete radiotherapy or absence of baseline audiology testing
•Pre-existing otological condition (i.e Meniere’s disease) that may influence the outcome of audiological assessment
•The patient should not be in state or condition that is expected to influence the outcome of treatment, complicate the audiological assessment or follow-up, or reduce life expectancy (apart from the present disease)
•Sufficient proficiency in English, cognitive capacity and willingness to complete questionnaires

发起方

Phoebe Shorter